Pathology Research and Practice

Papers
(The H4-Index of Pathology Research and Practice is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19130
Cancer immunotherapy: Challenges and limitations78
The role of miRNAs in liver diseases: Potential therapeutic and clinical applications66
PI3K/Akt/mTOR signaling pathway in cancer stem cells59
Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase58
A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay57
Immunotherapy of gastric cancer: Past, future perspective and challenges57
miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay – A review56
miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers54
Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-18454
Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways52
STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology52
The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways51
The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay50
Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer49
miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses48
miRNAs as potential game-changers in melanoma: A comprehensive review48
miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay47
miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses44
Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review44
The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy44
LncRNA signature in colorectal cancer43
COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences42
Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications41
Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review40
LncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision38
The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay37
The emerging roles of NGS in clinical oncology and personalized medicine36
PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy36
COL1A1: A novel oncogenic gene and therapeutic target in malignancies36
Immune checkpoints and cancer development: Therapeutic implications and future directions36
miR-509–5p promotes colorectal cancer cell ferroptosis by targeting SLC7A1135
Resveratrol attenuates rotenone-induced inflammation and oxidative stress via STAT1 and Nrf2/Keap1/SLC7A11 pathway in a microglia cell line35
The potential role of miRNAs in the pathogenesis of salivary gland cancer – A Focus on signaling pathways interplay35
Role of GATA3 in tumor diagnosis: A review34
0.050915002822876